The current study provides an overview of the pharmacogenomic landscape of NAT2 SNPs among TB and AT-DILI patients across two different geographical regions of India, comparing it to TB populations from other parts of the world and populations with different genetic ancestries from the ‘All of Us’ Research Program database. Here, NAT2 is linked to tuberculosis.